Consistent with these, gastric carcinomas have been reported to use α6β4 integrin and newly deposited laminins to adhere to surrounding tissues during the invasion [43], and Koike et al. [44] showed that invasive behavior of gastric cancer cells was inhibited by treatment with anti-α6 integrin antibody. The gene discussed is LAMB2; the disease is gastric carcinoma.